| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |